Index - P/E - EPS (ttm) -0.25 Insider Own 2.94% Shs Outstand 91.26M Perf Week -3.90%
Market Cap 6.49B Forward P/E 17.44 EPS next Y 4.03 Insider Trans -6.46% Shs Float 89.71M Perf Month -6.99%
Income -21.67M PEG - EPS next Q 0.80 Inst Own 101.13% Short Float 4.16% Perf Quarter -17.69%
Sales 2.93B P/S 2.22 EPS this Y 2.96% Inst Trans -8.01% Short Ratio 6.59 Perf Half Y -8.36%
Book/sh 30.48 P/B 2.30 EPS next Y 13.73% ROA -0.42% Short Interest 3.73M Perf Year -3.73%
Cash/sh 1.08 P/C 64.90 EPS next 5Y 10.12% ROE -0.77% 52W Range 66.49 - 87.77 Perf YTD -9.65%
Dividend Est. - P/FCF 169.96 EPS past 5Y 34.75% ROI -0.51% 52W High -19.95% Beta 1.33
Dividend TTM - Quick Ratio 0.67 Sales past 5Y 1.29% Gross Margin 23.31% 52W Low 5.67% ATR (14) 1.73
Dividend Ex-Date - Current Ratio 0.67 EPS Y/Y TTM -107.50% Oper. Margin 17.30% RSI (14) 27.17 Volatility 2.25% 2.16%
Employees 23500 Debt/Eq 0.54 Sales Y/Y TTM 12.20% Profit Margin -0.74% Recom 1.69 Target Price 95.85
Option/Short Yes / Yes LT Debt/Eq 0.52 EPS Q/Q -5.55% Payout - Rel Volume 0.85 Prev Close 70.16
Sales Surprise 2.09% EPS Surprise 7.24% Sales Q/Q 10.00% Earnings May 01 AMC Avg Volume 565.73K Price 70.26
SMA20 -6.09% SMA50 -11.27% SMA200 -8.22% Trades
Volume 480,588 Change 0.14%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Initiated Barclays
Overweight
$100
Apr-21-23 Initiated Cantor Fitzgerald
Neutral
$83
Apr-20-23 Downgrade Deutsche Bank
Hold → Sell
$75 → $63
Dec-12-22 Upgrade Loop Capital
Hold → Buy
$90 → $95
Jun-17-22 Initiated Loop Capital
Hold
$72
Sep-27-21 Initiated SVB Leerink
Outperform
$85
Sep-24-21 Initiated UBS
Buy
$81
Sep-20-21 Upgrade Credit Suisse
Neutral → Outperform
$68
Sep-10-21 Initiated Cowen
Outperform
$79
Aug-12-21 Initiated Barclays
Underweight
$69
Jul-09-21 Initiated Seaport Global Securities
Neutral
Nov-17-20 Upgrade UBS
Neutral → Buy
$37 → $54
Sep-30-20 Upgrade Raymond James
Outperform → Strong Buy
$40 → $48
Jan-28-20 Initiated Stephens
Equal-Weight
$36
Dec-11-19 Downgrade Wells Fargo
Outperform → Market Perform
Jul-31-19 Downgrade Raymond James
Strong Buy → Outperform
$45
Jan-03-19 Initiated Deutsche Bank
Hold
$27
Nov-16-18 Initiated UBS
Neutral
$39
Jan-30-18 Resumed Wells Fargo
Outperform
Nov-03-17 Initiated Credit Suisse
Neutral
Show Previous Ratings
Apr-12-24 11:52AM
Apr-11-24 02:16PM
Apr-05-24 11:54AM
Apr-04-24 09:00AM
Apr-03-24 01:25PM
11:00AM
Loading…
11:00AM
Apr-02-24 09:00AM
Apr-01-24 01:18PM
Mar-28-24 12:39PM
11:30AM
10:00AM
Mar-27-24 01:13PM
Mar-11-24 03:00PM
Mar-06-24 11:56PM
Mar-05-24 09:59AM
09:16AM
Loading…
Feb-29-24 09:16AM
Feb-28-24 09:53PM
(Thomson Reuters StreetEvents)
04:00PM
09:13AM
Feb-27-24 06:25PM
05:52PM
05:32PM
(Associated Press Finance)
04:05PM
Feb-23-24 11:12AM
Feb-21-24 03:06PM
Feb-20-24 01:00PM
Feb-15-24 03:04PM
Feb-07-24 10:00AM
Jan-30-24 01:32PM
Jan-24-24 09:40AM
12:56PM
Loading…
Jan-10-24 12:56PM
Jan-09-24 01:15PM
01:15PM
Jan-08-24 11:47AM
09:40AM
Jan-05-24 09:50AM
Jan-04-24 09:40AM
Jan-03-24 11:00AM
Dec-15-23 01:01PM
12:53PM
Dec-14-23 06:38PM
Dec-13-23 02:55PM
Dec-11-23 09:50AM
Dec-08-23 08:58AM
Dec-05-23 04:09PM
Nov-21-23 09:44AM
Nov-20-23 09:40AM
Nov-17-23 05:03AM
Nov-13-23 11:04PM
Nov-09-23 11:00AM
Nov-05-23 01:50PM
Nov-03-23 10:59PM
(Thomson Reuters StreetEvents)
11:52AM
09:40AM
08:52AM
Nov-02-23 07:22PM
05:34PM
(Associated Press Finance)
04:11PM
Nov-01-23 01:54PM
Oct-26-23 04:05PM
03:15PM
Oct-23-23 09:50AM
Oct-12-23 11:37AM
Oct-11-23 09:55AM
Oct-10-23 09:40AM
Oct-09-23 09:45AM
Sep-29-23 08:38AM
Sep-27-23 12:00PM
09:35AM
Sep-25-23 12:47PM
Sep-20-23 07:18AM
Sep-15-23 09:40AM
Sep-13-23 09:45AM
Sep-01-23 09:00AM
Aug-30-23 09:40AM
Aug-24-23 11:47AM
Aug-07-23 06:16AM
Aug-03-23 01:46PM
Jul-30-23 08:31AM
Jul-29-23 12:31AM
(Thomson Reuters StreetEvents)
Jul-28-23 12:42PM
Jul-27-23 06:55PM
05:54PM
04:05PM
Jul-25-23 12:04PM
Jul-24-23 04:05PM
04:05PM
11:42AM
Jul-18-23 11:30AM
Jul-17-23 05:40PM
Jul-09-23 09:53AM
Jul-06-23 12:00PM
Jul-03-23 11:29AM
Jun-30-23 12:15PM
12:15PM
Jun-21-23 08:00PM
06:34AM
Jun-16-23 11:45AM
Jun-15-23 02:00PM
02:00PM
Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services across the United States. The firm provides services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. The company was founded in January 2005 and is headquartered in Franklin, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Miquelon Wade D Director Mar 05 '24 Sale 85.39 2,203 188,114 46,074 Mar 06 05:30 PM Gregg Vicky B Director Mar 04 '24 Sale 85.56 2,500 213,900 26,851 Mar 06 05:28 PM OSTEEN DEBRA K Director Dec 13 '23 Sale 77.67 35,000 2,718,450 675,833 Dec 14 09:14 PM OSTEEN DEBRA K Director Dec 12 '23 Sale 76.23 8,000 609,840 710,833 Dec 14 09:14 PM Hollinsworth John S. EVP of Operations Nov 14 '23 Sale 74.01 92,500 6,846,300 84,630 Nov 16 05:01 PM Hollinsworth John S. EVP of Operations Nov 10 '23 Sale 73.00 20,000 1,460,000 177,130 Nov 13 05:42 PM OSTEEN DEBRA K Director Nov 08 '23 Sale 74.21 15,000 1,113,150 718,833 Nov 13 05:33 PM Hollinsworth John S. EVP of Operations Nov 08 '23 Sale 74.50 12,500 931,250 197,130 Nov 13 05:42 PM
Index - P/E 11.46 EPS (ttm) 0.45 Insider Own 28.05% Shs Outstand 47.65M Perf Week -3.36%
Market Cap 249.25M Forward P/E 30.41 EPS next Y 0.17 Insider Trans -0.82% Shs Float 34.68M Perf Month -3.36%
Income 21.59M PEG - EPS next Q -0.22 Inst Own 55.26% Short Float 9.50% Perf Quarter 3.82%
Sales 235.64M P/S 1.06 EPS this Y -42.22% Inst Trans -2.11% Short Ratio 5.68 Perf Half Y 119.07%
Book/sh 1.12 P/B 4.61 EPS next Y -34.62% ROA 9.54% Short Interest 3.29M Perf Year 94.36%
Cash/sh 1.99 P/C 2.60 EPS next 5Y - ROE 57.54% 52W Range 2.13 - 7.73 Perf YTD 19.40%
Dividend Est. - P/FCF 9.28 EPS past 5Y - ROI 17.12% 52W High -33.12% Beta 1.29
Dividend TTM - Quick Ratio 1.50 Sales past 5Y -0.59% Gross Margin 73.40% 52W Low 142.72% ATR (14) 0.35
Dividend Ex-Date - Current Ratio 1.57 EPS Y/Y TTM 15796.55% Oper. Margin 14.12% RSI (14) 46.06 Volatility 5.71% 5.98%
Employees 185 Debt/Eq 2.09 Sales Y/Y TTM 3.34% Profit Margin 9.16% Recom 3.00 Target Price 4.33
Option/Short Yes / Yes LT Debt/Eq 1.36 EPS Q/Q 308.66% Payout 0.00% Rel Volume 0.46 Prev Close 5.01
Sales Surprise -1.84% EPS Surprise -13.33% Sales Q/Q 9.90% Earnings May 02 AMC Avg Volume 579.91K Price 5.17
SMA20 -4.12% SMA50 -8.68% SMA200 25.20% Trades
Volume 265,408 Change 3.19%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-28-21 Upgrade Citigroup
Neutral → Buy
$11
Jun-25-20 Resumed BofA/Merrill
Underperform
$9
Oct-08-19 Downgrade Goldman
Neutral → Sell
$24 → $8
May-10-19 Downgrade Citigroup
Buy → Neutral
$24
May-10-19 Downgrade Cantor Fitzgerald
Overweight → Neutral
$57 → $20
Jan-17-19 Initiated Leerink Partners
Mkt Perform
$21
Jan-03-19 Downgrade Guggenheim
Buy → Neutral
Nov-19-18 Upgrade Goldman
Sell → Neutral
Nov-02-18 Downgrade JP Morgan
Neutral → Underweight
Nov-02-18 Downgrade BofA/Merrill
Buy → Underperform
Oct-01-18 Initiated Cantor Fitzgerald
Overweight
$75
Sep-17-18 Initiated Goldman
Sell
$42
May-11-18 Reiterated Stifel
Buy
$95 → $87
Nov-10-17 Reiterated RBC Capital Mkts
Sector Perform
$92 → $108
Nov-10-17 Reiterated Citigroup
Buy
$156 → $164
Oct-02-17 Reiterated Stifel
Buy
$110 → $130
Sep-11-17 Reiterated Credit Suisse
Outperform
$118 → $136
Jul-10-17 Resumed Leerink Partners
Outperform
$115
Jun-06-17 Reiterated RBC Capital Mkts
Sector Perform
$60 → $88
May-25-17 Reiterated RBC Capital Mkts
Sector Perform
$40 → $60
Show Previous Ratings
Apr-18-24 04:15PM
Apr-11-24 06:00PM
Apr-03-24 05:30PM
Mar-22-24 09:25AM
Mar-20-24 08:30AM
08:29AM
Loading…
Mar-02-24 08:29AM
Mar-01-24 09:55AM
(Thomson Reuters StreetEvents) -5.31%
09:40AM
09:39AM
Feb-29-24 04:41PM
04:40PM
(Associated Press Finance)
04:05PM
Feb-27-24 06:30PM
11:51AM
Feb-22-24 04:10PM
04:10PM
Loading…
Feb-15-24 04:10PM
Feb-13-24 08:30AM
Jan-31-24 12:58PM
Jan-11-24 04:07PM
Jan-06-24 11:02AM
Dec-11-23 08:30AM
Nov-20-23 11:47AM
Nov-06-23 05:15PM
Nov-03-23 12:16PM
09:34AM
(Thomson Reuters StreetEvents)
09:31AM
Nov-02-23 07:42PM
04:47PM
(Associated Press Finance)
04:05PM
Oct-19-23 04:14PM
12:30PM
Loading…
Oct-14-23 12:30PM
Oct-04-23 05:30PM
Sep-22-23 07:57AM
Sep-21-23 04:10PM
Aug-31-23 04:07PM
Aug-08-23 08:30AM
Aug-04-23 12:36PM
09:23AM
(Thomson Reuters StreetEvents)
Aug-03-23 05:17PM
04:05PM
Jul-20-23 04:15PM
Jun-13-23 09:30AM
Jun-06-23 05:03PM
Jun-04-23 09:00AM
May-28-23 10:06AM
May-22-23 11:07AM
May-05-23 05:15PM
12:45PM
09:44AM
(Thomson Reuters StreetEvents)
May-04-23 05:32PM
04:04PM
Apr-20-23 04:15PM
Apr-17-23 06:49AM
Apr-11-23 05:15PM
Mar-14-23 08:30AM
Mar-06-23 09:48AM
Mar-03-23 05:15PM
02:20PM
06:22AM
(Thomson Reuters StreetEvents)
Mar-02-23 04:05PM
Feb-28-23 04:15PM
Feb-19-23 02:05PM
Feb-16-23 04:31PM
Feb-07-23 05:30PM
Feb-01-23 08:30AM
Jan-25-23 06:19AM
Jan-12-23 04:15PM
Jan-11-23 05:30PM
Jan-09-23 08:55AM
Dec-20-22 08:31AM
Dec-15-22 03:39PM
Dec-07-22 06:03PM
Dec-05-22 05:30PM
Dec-01-22 08:36AM
Nov-28-22 09:55AM
Nov-22-22 09:15AM
08:50AM
Nov-21-22 05:25PM
Nov-17-22 09:40AM
Nov-14-22 10:10AM
09:50AM
Nov-11-22 10:20AM
Nov-09-22 10:43AM
06:02AM
Nov-07-22 01:02PM
(Simply Wall St.) +15.50%
Nov-04-22 12:29PM
12:20PM
12:18PM
11:18AM
Nov-03-22 06:45PM
04:05PM
Nov-02-22 05:30PM
Oct-27-22 04:05AM
Oct-20-22 04:15PM
Oct-12-22 09:31AM
Oct-04-22 05:30PM
Sep-21-22 11:35AM
10:15AM
Sep-20-22 04:05PM
Sep-11-22 05:15AM
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
AUERBACH ALAN H President and CEO Jan 03 '24 Sale 4.49 41,396 185,698 6,936,947 Jan 05 06:56 PM NOUGUES MAXIMO F Chief Financial Officer Jan 03 '24 Sale 4.49 15,682 70,348 128,666 Jan 05 06:49 PM Ludwig Jeffrey Jerome Chief Commercial Officer Jan 03 '24 Sale 4.49 12,956 58,119 99,970 Jan 05 07:00 PM HUNT DOUGLAS M See Remarks Jan 03 '24 Sale 4.49 8,358 37,493 103,319 Jan 05 06:42 PM Wong Alvin F Chief Scientific Officer Jan 03 '24 Sale 4.49 7,733 34,689 98,214 Jan 05 07:03 PM Wong Alvin F Chief Scientific Officer Dec 04 '23 Sale 3.76 280 1,053 97,934 Jan 10 04:41 PM MILLER MICHAEL PATRICK Director Nov 07 '23 Sale 2.83 25,000 70,802 43,358 Nov 09 04:19 PM AUERBACH ALAN H President and CEO Jul 03 '23 Sale 3.31 60,698 200,983 6,978,343 Jul 06 07:03 PM NOUGUES MAXIMO F Chief Financial Officer Jul 03 '23 Sale 3.31 14,680 48,608 144,348 Jul 06 07:12 PM Ludwig Jeffrey Jerome Chief Commercial Officer Jul 03 '23 Sale 3.31 12,103 40,075 112,926 Jul 06 07:08 PM HUNT DOUGLAS M See Remarks Jul 03 '23 Sale 3.31 7,809 25,857 111,677 Jul 06 07:06 PM Wong Alvin F Chief Scientific Officer Jul 03 '23 Sale 3.31 6,938 22,973 105,947 Jul 06 07:16 PM Senderowicz Adrian Director Jun 13 '23 Sale 3.45 27,000 93,280 0 Jun 15 09:03 PM WILSON TROY EDWARD Director Jun 13 '23 Sale 3.45 27,000 93,269 350 Jun 15 09:14 PM MOYES JAY M Director Jun 13 '23 Sale 3.45 22,000 75,970 16,322 Jun 15 09:10 PM MILLER MICHAEL PATRICK Director Jun 13 '23 Sale 3.45 13,500 46,630 41,358 Jun 15 08:28 PM Dorval Allison Director Jun 13 '23 Sale 3.45 10,000 34,500 17,000 Jun 15 09:01 PM Stuglik Brian M Director Jun 13 '23 Sale 3.46 9,900 34,252 31,958 Jun 15 09:06 PM Wong Alvin F Chief Scientific Officer Jun 02 '23 Sale 3.45 269 928 112,885 Jun 06 04:36 PM
Index - P/E - EPS (ttm) -19.90 Insider Own 5.78% Shs Outstand 4.76M Perf Week -2.77%
Market Cap 70.07M Forward P/E 2.16 EPS next Y 6.80 Insider Trans 0.52% Shs Float 4.48M Perf Month -3.22%
Income -95.63M PEG - EPS next Q 0.70 Inst Own 31.94% Short Float 3.05% Perf Quarter -18.18%
Sales 371.34M P/S 0.19 EPS this Y 222148.48% Inst Trans -43.69% Short Ratio 6.37 Perf Half Y 22.46%
Book/sh 11.80 P/B 1.25 EPS next Y 19.72% ROA -14.81% Short Interest 0.14M Perf Year -33.69%
Cash/sh 4.82 P/C 3.05 EPS next 5Y 20.00% ROE -27.55% 52W Range 9.60 - 22.60 Perf YTD -11.86%
Dividend Est. - P/FCF 2.56 EPS past 5Y 18.48% ROI -35.82% 52W High -34.87% Beta 1.08
Dividend TTM - Quick Ratio 0.54 Sales past 5Y -2.29% Gross Margin 42.56% 52W Low 53.33% ATR (14) 0.83
Dividend Ex-Date - Current Ratio 0.54 EPS Y/Y TTM -12.75% Oper. Margin 3.32% RSI (14) 38.24 Volatility 5.10% 5.16%
Employees 1250 Debt/Eq 0.19 Sales Y/Y TTM -1.35% Profit Margin -25.75% Recom 1.67 Target Price 22.00
Option/Short No / Yes LT Debt/Eq 0.09 EPS Q/Q -731.50% Payout - Rel Volume 1.62 Prev Close 14.45
Sales Surprise -2.53% EPS Surprise -56.36% Sales Q/Q -3.20% Earnings Mar 06 AMC Avg Volume 21.42K Price 14.72
SMA20 -4.53% SMA50 -12.03% SMA200 -1.83% Trades
Volume 34,746 Change 1.87%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-10-21 Reiterated Needham
Buy
$6 → $4.50
Jun-28-21 Initiated Craig Hallum
Buy
$7
Jan-11-21 Upgrade Loop Capital
Hold → Buy
$3 → $4
Feb-28-20 Reiterated Aegis Capital
Buy
$7 → $8
May-10-19 Reiterated Needham
Buy
$28 → $15
Apr-02-19 Reiterated Aegis Capital
Buy
$30 → $25
Apr-01-19 Downgrade SunTrust
Buy → Hold
Apr-01-19 Downgrade Loop Capital
Buy → Hold
Mar-04-19 Resumed SunTrust
Buy
$27
Mar-01-19 Reiterated Needham
Buy
$20 → $28
Nov-29-18 Initiated Needham
Buy
$20
Oct-11-18 Initiated Aegis Capital
Buy
$29
Jun-12-18 Initiated Loop Capital
Buy
$32
Show Previous Ratings
Apr-22-24 08:00AM
07:00AM
Apr-19-24 08:44PM
Apr-05-24 09:35AM
Apr-03-24 08:11AM
11:24AM
Loading…
Mar-27-24 11:24AM
Mar-20-24 08:00AM
Mar-12-24 09:00AM
Mar-07-24 10:52AM
08:42AM
(Thomson Reuters StreetEvents)
Mar-06-24 09:54PM
05:10PM
04:00PM
02:56AM
Mar-05-24 10:54AM
08:30AM
Loading…
Mar-01-24 08:30AM
Feb-29-24 08:33PM
Feb-23-24 08:00AM
Feb-22-24 08:00AM
Feb-21-24 11:43PM
(Thomson Reuters StreetEvents)
Feb-18-24 03:09PM
(The Wall Street Journal)
Feb-06-24 12:54PM
Jan-31-24 09:30AM
Jan-23-24 09:00AM
Jan-16-24 09:00AM
Jan-10-24 10:06AM
Dec-29-23 04:00PM
Dec-27-23 04:29PM
09:37AM
Dec-24-23 03:39PM
11:52AM
Loading…
Dec-20-23 11:52AM
11:51AM
11:51AM
Dec-18-23 08:00AM
Nov-30-23 08:00AM
Nov-07-23 09:30AM
08:00AM
07:32AM
(Thomson Reuters StreetEvents)
Nov-06-23 04:39PM
04:10PM
Oct-31-23 09:31AM
09:00AM
Oct-26-23 08:00AM
12:24AM
Oct-25-23 08:00AM
Oct-24-23 09:00AM
Sep-26-23 09:00AM
Sep-12-23 08:00AM
Aug-29-23 08:42AM
Aug-21-23 02:07PM
Aug-18-23 03:28AM
Aug-10-23 09:43AM
Aug-09-23 03:19PM
(American City Business Journals) +9.75%
09:28AM
(Thomson Reuters StreetEvents)
Aug-08-23 08:05PM
04:02PM
Jul-21-23 07:00AM
Jul-17-23 08:59AM
Jul-14-23 06:07AM
Jun-14-23 11:03AM
Jun-13-23 09:00AM
Jun-07-23 07:00AM
May-24-23 07:00AM
May-20-23 08:25AM
May-18-23 10:00AM
09:55AM
May-17-23 09:35AM
May-16-23 07:00AM
07:00AM
May-11-23 09:35AM
May-10-23 09:25AM
(Thomson Reuters StreetEvents) -9.13%
May-09-23 06:35PM
04:15PM
May-04-23 09:00AM
08:05AM
Apr-26-23 08:15AM
Apr-25-23 07:00AM
Mar-28-23 09:00AM
Mar-23-23 07:00AM
Mar-01-23 07:11AM
(Thomson Reuters StreetEvents)
Feb-28-23 07:55PM
04:05PM
06:43AM
Feb-27-23 11:42AM
06:50AM
Feb-24-23 07:17AM
Feb-23-23 07:21AM
Feb-22-23 06:56AM
Feb-21-23 07:35AM
Feb-17-23 08:00AM
06:27AM
Feb-16-23 07:28AM
Feb-15-23 07:01AM
Feb-14-23 06:23AM
Feb-13-23 07:30AM
Feb-10-23 06:42AM
Feb-09-23 06:51AM
Feb-08-23 06:45AM
05:19AM
Feb-07-23 06:46AM
comScore, Inc. is a global information and analytics company, which engages in the measurement of audiences, consumer behavior, and advertising across media platforms. The company was founded by Magid M. Abraham and Gian Mark Fulgoni in August 1999 and is headquartered in Reston, VA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
180 DEGREE CAPITAL CORP. /NY/ See Explanation of Responses Apr 03 '24 Buy 14.94 1,417 21,170 27,542 Apr 05 08:26 AM ALGRANATI DAVID Chief Innovation Officer Mar 10 '24 Option Exercise 0.00 2,360 0 13,486 Mar 12 06:48 PM Carpenter Jonathan Chief Executive Officer Nov 29 '23 Option Exercise 0.00 150,659 0 332,318 Nov 30 04:28 PM Curry Mary Margaret See Remarks Aug 17 '23 Buy 0.73 15,000 10,950 36,867 Aug 21 07:15 AM Wendling Brian J Director Aug 17 '23 Buy 0.73 10,353 7,558 267,069 Aug 17 04:05 PM Wendling Brian J Director Aug 16 '23 Buy 0.76 39,647 30,132 256,716 Aug 17 04:05 PM Carpenter Jonathan Chief Executive Officer Aug 16 '23 Buy 0.77 5,000 3,850 181,659 Aug 17 08:38 AM Carpenter Jonathan Chief Executive Officer Aug 11 '23 Buy 0.81 7,500 6,075 176,659 Aug 15 04:14 PM Patterson Martin Edward Director Jun 20 '23 Buy 0.89 9,000 8,010 190,569 Jun 21 08:11 PM CHARTER COMMUNICATIONS, INC. / 10% Owner Jun 15 '23 Option Exercise 0.00 200,000 0 344,246 Jun 16 05:06 PM Patterson Martin Edward Director Jun 15 '23 Option Exercise 0.00 100,000 0 181,569 Jun 16 07:42 PM Wendling Brian J Director Jun 15 '23 Option Exercise 0.00 100,000 0 217,069 Jun 16 07:43 PM Banerjee Nana Director Jun 15 '23 Option Exercise 0.00 100,000 0 129,400 Jun 16 07:41 PM FISHER ITZHAK Director Jun 15 '23 Option Exercise 0.00 100,000 0 277,069 Jun 16 07:42 PM Love Kathleen Director Jun 15 '23 Option Exercise 0.00 100,000 0 281,431 Jun 16 07:40 PM Rosenthal Brent David Director Jun 15 '23 Option Exercise 0.00 100,000 0 929,699 Jun 16 07:41 PM LIVEK WILLIAM PAUL Director Jun 15 '23 Option Exercise 0.00 100,000 0 3,723,261 Jun 16 07:39 PM Gillin Leslie Director Jun 15 '23 Option Exercise 0.00 84,000 0 84,000 Jun 16 07:40 PM LIVEK WILLIAM PAUL Director May 19 '23 Buy 0.98 175,642 172,129 3,623,261 May 22 08:22 AM LIVEK WILLIAM PAUL Director May 18 '23 Buy 0.88 124,358 109,435 3,447,619 May 22 08:22 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
